ReviewFrontiers in molecular neuroscience2019
Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease.
Carroll Rutherford Fields et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
166 papers cite itlatest 60 shown
this paperpooled ittrialcites it